Some studies also highlight the potential for GLP-1 RAs to reduce upper airway fat deposition and systemic inflammation, thereby directly targeting key contributors to OSA beyond weight loss alone (108, 111). Here, GCG is linked to obstructive sleep apnea syndrome.